Serum 1,25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases

Background: Impaired vitamin D metabolism may contribute to the development and progression of chronic kidney disease. The purpose of this study was to determine associations of circulating vitamin D with the degree of proteinuria and estimated glomerular filtration rate (eGFR) in patients with biopsy-proven glomerular diseases. Methods: Clinical and biochemical data including blood samples for 25-hydroxyvitamin D (25(OH) D) and 1,25-dihydroxyvitamin D (1,25(OH)(2)D) levels were collected from patients at the time of kidney biopsy. Results: Serum 25(OH) D levels were not different according to eGFR. However, renal function was significantly decreased with lower serum 1,25(OH)(2)D levels (P < 0.001). The proportions of nephrotic-range proteinuria and renal dysfunction (eGFR <= 60 mL/min/1.73 m(2)) progressively increased with declining 1,25(OH)(2)D but not 25(OH)D. Multivariable linear regression analysis showed that 25(OH)D was significantly correlated with serum albumin and total cholesterol (beta = 0.224, P = 0.006; beta = -0.263, P = 0.001) and 1,25(OH)(2)D was significantly correlated with eGFR, serum albumin and phosphorus (beta = 0.202, P = 0.005; beta = 0.304, P < 0.001; beta = -0.161, P = 0.024). In adjusted multivariable linear regression, eGFR and 24hr proteinuria were independently correlated only with 1,25(OH)(2)D (beta = 0.154, P = 0.018; beta = -0.171, P = 0.012), but not 25(OH) D. The lower level of 1,25(OH)(2)D was associated with the frequent use of immunosuppressive agents (P < 0.001). Conclusion: It is noteworthy in these results that circulating 1,25(OH)(2)D may be superior to 25(OH) D as a marker of severity of glomerular diseases.